Craig McGlashan

Permira prescribes generative AI and acquisitions for Ergomed

The private equity firm took pharma services company Ergomed private in November.

Armen readying second GP stakes deal

‘There is a lot of pipeline, but it takes time for LPs to get comfortable with a new strategy,’ says CEO Laurent Benard.

Thoma Bravo closes EQS take-private

Battery Ventures to buy Ortec; LionRock’s Haglöfs plans.

General Atlantic to buy Actis in latest infra tie-up; Vesey Street, Aquiline add to busy pharma sector

General Atlantic moves for sustainable infrastructure firm Actis; S&P Global Market Intelligence confirms what we already knew – that 2023 had a big drop-off in dealmaking; new pharma deals from Vesey Street Capital and Aquiline Capital; Battery Ventures' majority investment in a decision-support software and data science company.

Battery Ventures to acquire majority stake in Ortec

The private equity firm will help the decision-support software and data science company bolster its product offering via acquisitions, says partner Zak Ewen.

Bain Capital’s SoftwareOne offer fails to win over board

CVC to buy restaurant chain from Permira.

Riverside exits rum biz to Platinum Equity after doubling EBITDA

Bluegem on pros of strategic sales.

Private equity firms lean on strategic exits with M&A still tough

Bluegem’s sale of Dr Vranjes Firenze relied on ‘a process tailored to trade buyers who are less affected by the expensive financing’, says founding partner Emilio Di Spiezio Sardo.

Pictet plans add-ons for facilities manager

Main makes first Swiss acquisition.

Main Capital’s Aunetic looks to DACH with LARI digital acquisition

LARI digital is a legal and regulatory intelligence software provider.